drchrono releases API for developers

Article

Drchrono, Inc. recently launched its application programming interface (API) that will allow developers to build their own healthcare applications.

Mountain View, CA-Drchrono, Inc., the creator of a free electronic medical record (EMR) platform on the iPad, iPhone, and cloud, recently released its application programming interface (API)
 that will allow developers to build their own healthcare applications on top of the drchrono platform.

Only 1.3% of APIs listed on ProgrammableWeb, an API database, are associated with the medical services sector. Innovators have avoided developing applications for the healthcare industry due to high regulations and the difficulty in accessing APIs from health institutions. Drchrono wants to ease developers’ requests to the API as easy as a sign-up and one-week review process. Drchrono would like to encourage developers to find opportunities in the evolving healthcare space to launch new companies. The current procedure for accessing a health institution’s API involves working with the organization’s business development team, a potentially lengthy process. Because each institution uses its own API, it can be a very time consuming process for companies to access it. By leveraging drchrono, these organizations can access their patients’ information for application construction within a week. 

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.